Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clifton E Barry

Showing results (21-30 of 264) with videos related to

Pageof 27
Sort By:
The Journal of Antimicrobial Chemotherapy|October 11, 2011
Comment on: Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonaeTathagata Mukherjee, Helena Boshoff, Clifton E Barry
Communicative & Integrative Biology|July 31, 2009
The mechanism of action of PA-824: Novel insights from transcriptional profilingUjjini Manjunatha, Helena Im Boshoff, Clifton E Barry
Infection and Immunity|May 24, 2005
Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistancePilar Domenech, Michael B Reed, Clifton E Barry
American Journal of Respiratory and Critical Care Medicine|March 23, 2022
Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the TunnelChristoph Lange, Clifton E Barry, C Robert Horsburgh
The New England Journal of Medicine|November 26, 2015
Treatment of TuberculosisC Robert Horsburgh, Clifton E Barry, Christoph Lange
Journal of Bacteriology|March 27, 2002
Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase IHelena I Boshoff, Valerie Mizrahi, Clifton E Barry
Tetrahedron Letters|May 16, 2006
Novel route to 5-position vinyl derivatives of thiolactomycin: Olefination vs. deformylationPilho Kim, Clifton E Barry, Cynthia S Dowd
Drug Discovery Today|December 27, 2011
Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategiesHanif Esmail, Clifton E Barry, Robert J Wilkinson
Lancet (London, England)|May 22, 2010
Age and the epidemiology and pathogenesis of tuberculosisPeter R Donald, Ben J Marais, Clifton E Barry
Infectious Disorders Drug Targets|November 1, 2007
Targeting the formation of the cell wall core of M. tuberculosisClifton E Barry, Dean C Crick, Michael R McNeil
Pageof 27

Showing results (21-30 of 264) with videos related to

Sort By:
Pageof 27
The Journal of Antimicrobial Chemotherapy|October 11, 2011
Comment on: Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonaeTathagata Mukherjee, Helena Boshoff, Clifton E Barry
Communicative & Integrative Biology|July 31, 2009
The mechanism of action of PA-824: Novel insights from transcriptional profilingUjjini Manjunatha, Helena Im Boshoff, Clifton E Barry
Infection and Immunity|May 24, 2005
Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistancePilar Domenech, Michael B Reed, Clifton E Barry
American Journal of Respiratory and Critical Care Medicine|March 23, 2022
Treatments of Multidrug-Resistant Tuberculosis: Light at the End of the TunnelChristoph Lange, Clifton E Barry, C Robert Horsburgh
The New England Journal of Medicine|November 26, 2015
Treatment of TuberculosisC Robert Horsburgh, Clifton E Barry, Christoph Lange
Journal of Bacteriology|March 27, 2002
Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase IHelena I Boshoff, Valerie Mizrahi, Clifton E Barry
Tetrahedron Letters|May 16, 2006
Novel route to 5-position vinyl derivatives of thiolactomycin: Olefination vs. deformylationPilho Kim, Clifton E Barry, Cynthia S Dowd
Drug Discovery Today|December 27, 2011
Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategiesHanif Esmail, Clifton E Barry, Robert J Wilkinson
Lancet (London, England)|May 22, 2010
Age and the epidemiology and pathogenesis of tuberculosisPeter R Donald, Ben J Marais, Clifton E Barry
Infectious Disorders Drug Targets|November 1, 2007
Targeting the formation of the cell wall core of M. tuberculosisClifton E Barry, Dean C Crick, Michael R McNeil
Pageof 27